Pilot study of the efficacy of a thrombin inhibitor for use during cardiopulmonary bypass
Open Access
- 1 August 1994
- journal article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 58 (2), 344-350
- https://doi.org/10.1016/0003-4975(94)92206-3
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Selective thrombin inhibitors: The next generation of anticoagulantsJournal of the American College of Cardiology, 1993
- Heparin-associated Thrombocytopenia: A Critical Review and Pooled AnalysisThe American Journal of the Medical Sciences, 1993
- A DNA aptamer which binds to and inhibits thrombin exhibits a new structural motif for DNABiochemistry, 1993
- Selection of single-stranded DNA molecules that bind and inhibit human thrombinNature, 1992
- Potential use of recombinant hirudin as an anticoagulant in a cardiopulmonary bypass modelThe Annals of Thoracic Surgery, 1991
- Management of Patients with Heparin-Associated Thrombocytopenia and Thrombosis Requiring Cardiac SurgeryThe Annals of Thoracic Surgery, 1987
- Pharmacological, Hematological, and Physiological Effects of a New Thromboxane Synthetase Inhibitor (CGS-13080) During Cardiopulmonary Bypass in DogsThe Annals of Thoracic Surgery, 1986
- Heparin Resistance prior to Cardiopulmonary BypassAnesthesiology, 1986
- LOW-MOLECULAR-WEIGHT HEPARIN IN EXTRACORPOREAL CIRCULATIONThe Lancet, 1984
- Adequate Anticoagulation During Cardiopulmonary Bypass Determined by Activated Clotting Time and the Appearance of Fibrin MonomerThe Annals of Thoracic Surgery, 1978